Document is current
Any future updates will be listed below
-
Authors
Yilmaz, Sule
Aryal, Komal
King, Jasmine
Bischof, Jason J.
Hong, Arthur S.
Wood, Nancy
Gould Rothberg, Bonnie E.
Hudson, Matthew F.
Heinert, Sara W.
Wattana, Monica K.
Coyne, Christopher J.
Reyes-Gibby, Cielito
Todd, Knox
Lyman, Gary
Klotz, Adam
Abar, Beau
Grudzen, Corita
Bastani, Aveh
Baugh, Christopher W.
Henning, Daniel J.
Bernstein, Steven
Rico, Juan Felipe
Ryan, Richard J.
Yeung, Sai-Ching Jim
Qdaisat, Aiham
Padela, Aasim
Madsen, Troy E.
Liu, Raymond
Adler, David
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 7 February 2025
First Online: 5 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: Bonnie E. Gould Rothberg: Stock Ownership: Butterfly Networks Inc., Quantum Si, Hyperfine Research, AI Therapeutics, Detect Labs, identifeye Health, Protein Evolution Inc.) and direct family members: #A) Stock Ownership: Butterfly Networks Inc., Quantum Si, Hyperfine Research, AI Therapeutics, Detect Labs, identifeye Health, Protein Evolution Inc., 454 Corporation, Electric Futures, (Abbvie Inc, Amgen inc, Biocryst Pharmaceuticals, Gilead Sciences, Inc, Regeneron Pharmaceuticals Inc, Roche Holdings, Pacific Biosciences of California Inc (sold 07/2023)), Telesis Bio Inc #B) Employment: Butterfly Networks Inc, 4Catalyzer #C) Significant Leadership: Butterfly Networks Inc, Quantum Si, Hyperfine Research, AI Therapeutics, identifyee Health, Detect Labs, Protein Evolution Inc. #D) Patents, Royalties, and Other Intellectual Property: Thermo Fisher, Butterfly Networks, Quantum Si, Hyperfine Research, AI Therapeutics, Tesseract, Detect Labs. Christopher William Baugh: paid speaker for Roche Diagnostics, Octapharma, and CE Symmetry, an investigator for Abbott Laboratories, an advisory board participant for Roche Diagnostics, Salix Pharmaceuticals, Pfizer Inc., and AstraZeneca, a consultant for Abbott, Pfizer, Roche, and an advisor to Lucia Health Guidelines. Sai-Ching Yeung: an advisory board participant Salix Pharmaceuticals. The remaining authors declare that they have no competing interests.Christopher William Baugh: paid speaker for Roche Diagnostics, Octapharma, and CE Symmetry, an investigator for Abbott Laboratories, an advisory board participant for Roche Diagnostics, Salix Pharmaceuticals, Pfizer Inc., and AstraZeneca, a consultant for Abbott, Pfizer, Roche, and an advisor to Lucia Health Guidelines.Sai-Ching Yeung: an advisory board participant Salix Pharmaceuticals.The remaining authors declare that they have no competing interests.
